Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-06-03

Clinical Trial Update: HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating HLA and its relation to the development of proliferative diabetic retinopathy in Mexican patients with diabetes mellitus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diabetes Mellitus Type 2, Proliferative Diabetic Retinopathy | Phase 3 | Status: WITHDRAWN